Pulmonary Disease Doctors in Livingston, NJ Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Dr. Kristin Gail Fless, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-2924    Fax: 973-322-8410

Dr. Martin Jay Greenberg, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 124 E Mount Pleasant Ave, Livingston, NJ 07039 Phone: 973-994-4130    Fax: 973-994-2977

Elena Burke, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000

Kenneth T Defusco, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2 W Northfield Rd, Livingston, NJ 07039 Phone: 973-994-1544    Fax: 973-994-2387

Dr. Thomas Reed Martin, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: One Health Plaza, Novartis Pharmaceuticals, Livingston, NJ 07936 Phone: 862-778-1549    Fax: 973-781-7387

News Archive

Closer to an effective treatment for gum disease in smokers

Scientists in the USA have discovered why smokers may be more prone to chronic gum disease (periodontitis). One of the bacteria responsible for this infection responds to cigarette smoke - changing its properties and the way it infects a smokers mouth.

Using social media to study vaccine acceptance in China

Vaccine acceptance is a crucial public health issue, which has been exacerbated by the use of social media to spread content expressing vaccine hesitancy.

FDA Advisory Committee recommends approval of dabigatran etexilate for stroke prevention in AFib patients

The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee today voted 9 to 0 in favor of approving dabigatran etexilate for stroke prevention in patients with atrial fibrillation (AFib). An estimated 2.3 million Americans have AFib and the prevalence is expected to increase 2.5 fold to 5.6 million by 2050, reflecting the growing population of elderly individuals.

European Commission approves SmPC update for VIRAMUNE in HIV treatment

Boehringer Ingelheim announced today that the European Commission has approved an update to the Summary of Product Characteristics (SmPC) for VIRAMUNE (nevirapine) in the treatment of patients with HIV.

Bayer Cropscience to invest $25 million for enhancing operational safety at its Institute site

Bayer CropScience today announced an investment of $25 million for further enhancing operational safety at its Institute, W.Va. site. As part of these plans, the company will reduce methyl isocyanate (MIC) storage by 80 percent.

Read more Medical News

› Verified 6 days ago